|
[1]
|
Orhan, I.E. (2012) Current concepts on selected plant secondary metabolites with promising inhibitory effects against enzymes linked to Alzheimer’s disease. Current Medicinal Chemistry, 19, 2252-2261.
|
|
[2]
|
Pohanka, M. (2011) Cholinesterases, a target of pharmacology and toxicology. Biomedical Papers of the Medical Faculty of the University Palacky, 155, 212-229.
doi:10.5507/bp.2011.036
|
|
[3]
|
Goodall, R. (2004) Cholinesterase: Phenotyping and geno- typing. Annals of Clinical Biochemistry, 41, 98-110.
doi:10.1258/000456304322879971
|
|
[4]
|
Taylor, P. (1991) The cholinesterases. Journal of Biologi- cal Chemistry, 266, 4025-4028.
|
|
[5]
|
Silman, I. and Sussman, J.L. (2008) Acetylcholinesterase: How is structure related to function? Chemico-Biological Interactions, 175, 3-10. doi:10.1016/j.cbi.2008.05.035
|
|
[6]
|
Cokugras, A.N. (2003) Butyrylcholinesterase: Structure and physiological importance. Turkish Journal of Biochemistry, 28, 54-61.
|
|
[7]
|
Maekawa, M., Sudo, K., Dey, D.C., Ishikawa, J., Izumi, M., Kotani. K. and Kanno, T. (1997) Genetic mutations of butyrylcholine esterase identified from phenotypic ab- normalities in Japan. Clinical Chemistry, 43, 924-929.
|
|
[8]
|
Levano, S., Ginz, H., Siegemund, M., Flipovic, M., Voronkov, E., Urwyler, A. and Girard, T. (2005) Genotyping the butyrylcholinesterase in patients with prolonged neuromuscular block after succinylcholine. Anesthesiology, 102, 531-535.
|
|
[9]
|
Parmo, S.L.P., Bartels, C.F., Wiersema, B., van der Spek, A.F., Innis, J.W. and La Du, B.N. (1996) Characterization of 12 silent alleles of the human butyrylcholinesterase (BCHE) gene. American Journal of Human Genetics, 58, 52-64.
|
|
[10]
|
Boberg, D.R., Alle, L.F., Soua, L.R. and Maia, E.A.C. (2010) Molecular forms of butrylcholinesterase and obe- sity. Genetics and Molecular Biology, 33, 452-454.
doi:10.1590/S1415-47572010005000072
|
|
[11]
|
Manoharan, I., Wieseler, S., Layer, P.G., Lockridge, O. and Boopathy, R. (2006) Naturally occurring mutation Leu307Pro of human butyrylcholinesterase in the Vysya community of India. Pharmacogenetics and Genomics, 16, 461-468.
|
|
[12]
|
Ciro, A., Park, J., Burkhard, G., Yan, N. and Geula, C. (2012) Biochemical differentiation of cholinesterases from nor- mal and Alzheimer’s disease cortex. Current Alzheimer Research, 9, 138-143. doi:10.2174/156720512799015127
|
|
[13]
|
Garcia-Ayllon, M.S., Riba-Liena, I., Serra-Basante, C., Alom, J., Boopathy, R. and Saez-Valero, J. (2010) Altered levels of acetylcholinesterase in Alzheimer plasma. PLoS One, 5, e8701.
|
|
[14]
|
Darvesh, S., Reid, G.A. and Martin, E. (2010) Biochemical and histochemical comparison of cholinesterases in normal and Alzheimer brain tissues. Current Alzheimer Research, 7, 386-400. doi:10.2174/156720510791383868
|
|
[15]
|
Podoly, E., Hanin, G. and Soreq, H. (2010) Alanine-to- threonine substitutions and amyloid diseases: Butyrylcho- linesterase as a case-study. Chemico-Biological Interactions, 187, 64-71. doi:10.1016/j.cbi.2010.01.003
|
|
[16]
|
Bullock, R. and Lane, R. (2007) Executive dyscontrol in dementia, with emhasis on subcortical pathology and the role of butyrylcholinesterase. Current Alzheimer Research, 4, 277-293. doi:10.2174/156720507781077313
|
|
[17]
|
Darreh-Shori, T., Forsberg, A., Modiri, N., Andreasen, N., Blennow, K., Kamil, C., Ahmed, H., Almkvist, O., Langstrom, B. and Nordberg, A. (2011) Differential levels of apolipoprotein E and butyrylcholinesterase show strong association with pathological signs of Alzheimer’s disease in the brain in vivo. Neurobiology of Aging, 32, e15- e32.
|
|
[18]
|
Lane, R.M. and He, Y. (2012) Butyrylcholinesterase geno- type and gender influence Alzheimer’s disease phenotype. Alzheimers Dement, in press.
doi:10.1016/j.jalz.2010.12.005
|
|
[19]
|
Darreh-Shori, T., Siawesh, M., Mousavi, M., Andreasen, N. and Nodberg, A. (2012) Apoliporotein E4 modulates phenotype of butyrylcholinesterase in CSF of patients with Alzheime’s disease. Journal of Alzheimers Disease, 28, 443-458.
|
|
[20]
|
Darreh-Shori, T., Modiri, N., Blennow, K., Baza, S., Ka- mil, C., Ahmed, H., Andreasen, N. and Nordberg, A. (2011) The apolipoprotein E ε4 allele plays pathological roles in AD through high protein expression and interacttion with butyrylcholinesterase. Neurobiology of Aging, 32, 1246- 1248. doi:10.1016/j.neurobiolaging.2009.07.015
|
|
[21]
|
Lane, R., Feldman, H.H., Meyer, J., He, Y., Ferris, S.H., Nordberg, A., Darreh-Shori, T., Soininen, H., Pirttila, T., Farlow, M.R., Sfikas, N., Ballard, C. and Greig, N.H. (2008) Synergistic effect of apolipoprotein E epsilon4 and bu- tyrylcholinesterase K-variant on progression from mild cognitive impairment to Alzheimer’s disease. Pharmaco- genet Genomics, 18, 289-298.
doi:10.1097/FPC.0b013e3282f63f29
|
|
[22]
|
Lane, R., He, Y., Morris, C., Leverenz, J.B., Emre, M. and Ballard, C. (2009) BuChe-K and APOE epsilon4 al- lele frequencies in Lewy body dementias, and influence of genotype and hyperhomocysteinemia on cognitive de- cline. Movement Disorders, 24, 392-400.
doi:10.1002/mds.22357
|
|
[23]
|
Mateo, I., Llorca, J., Infante, J., Rodriguez-Rodriguez, E., Berciano, J. and Combarros, O. (2008) Gene-gene inter- action between 14-3-3 zeta and butyrylcholinesterase modulates Alzheimer’s disease risk. European Journal of Neurology, 15, 219-222.
doi:10.1111/j.1468-1331.2008.02059.x
|
|
[24]
|
Sridhar, G.R., Rao, A.A., Srinivas, K., Nirmala, G., Lakshmi, G., et al. (2010) Butyrylcholinesterase in metabolic syndrome. Medical Hypotheses, 75, 648-651.
doi:10.1016/j.mehy.2010.08.008
|
|
[25]
|
Sridhar, G.R., Thota, H., Allam, A.R., et al. (2006) Alzheimer’s disease and type 2 diabetes mellitus: The cholinesterase connection? Lipids in Health and Disease, 5, 28.
doi:10.1186/1476-511X-5-28
|
|
[26]
|
Sridhar, G.R. and Nirmala, G. (2002) Inborn errors in lipid metabolism. In: Tripathy, B.B. and Das, S. Eds., Lipid Disorders, Association of Physicians of India, College of Physicians, Guwahati, 59-80.
|
|
[27]
|
Sridhar, G.R. (2011) Proteins of the esterase family: Patents for some proteins in search of metabolic functions. Recent Patents on Biomarkers, 1, 205-212.
|
|
[28]
|
Deniz-Naranjo, M.C., Munoz-Fernande, C., Alemany-Ro- driguez, M.J., del Perez-Vieitez, C.M., Aldro-Benito, Y., Irurita-Latasa, J. and Sanchez-Gracia, F. (2007) Butyrylcholinesterase, ApoE and Alzheimer’s disease in a popu- lation from the Canary Islands (Spain). Neuroscience Letters, 427, 34-38. doi:10.1016/j.neulet.2007.08.059
|
|
[29]
|
Piccardi, M., Congiu, D., Squassina, A., Manconi, F., Putzu, P.F., Mereu, R.M., Chillotti, C. and Del Zompo, M. (2007) Alzheimer’s disease: Case-control association stu- dy of polymorphisms in ACHE, CHAT, and BCHE genes in a Sardinian sample. American Journal of Medical Ge- netics Part B: Neuropsychiatric Genetics, 144B, 895-899.
doi:10.1002/ajmg.b.30548
|
|
[30]
|
Luschchekina, S.V., Grigorenko, B.L., Morozov, D.I., Polya- kov, I.V., Nemukhin, A.V. and Varfolomeev, S.D. (2010) Modeling of the mechanism of hydrolysis of succinylcholine in the active site of native and modified (Asp70Gly) human butyrylcholinesterase. Russian Chemical Bulletin, 59, 55-60. doi:10.1007/s11172-010-0044-0
|
|
[31]
|
Nicolet, Y., Lockridge, O., Masson, P., Fontecilla-camps, J.C. and Nachon, F. (2003) Crystal structure of human butyrylcholinesterase and of its complexes with substrate and products. Journal of Biological Chemistry, 278, 41141- 41147. doi:10.1074/jbc.M210241200
|
|
[32]
|
Ngamelue, M.N., Homma, K., Lockridge, O. and Asojo, O.A. (2007) Crystallization and X-Ray structure of full length recombinant human butyrylcholinesterase. Acta Crystallographica Section F: Structural Biology and Crys- tallization Communications, 63, 723-727.
doi:10.1107/S1744309107037335
|
|
[33]
|
Worth, C.L., Bickerton, G.R., Schreyer, A., Forman, J.R., Cheng, T.M., Lee, S., Gong, S., Burke, D.F. and Blundell, T.L. (2007) A structural bioinformatics approach to the analysis of nonsynonymous single nucleotide polymorphisms (nsSNPs) and their relation to disease. Journal of Bioinformatics and Computational Biology, 5, 1297-1318.
doi:10.1142/S0219720007003120
|
|
[34]
|
Hotelier, T., Renault, L., Cousin, X., Negre, V., Marchot, P. and Chatonnet, A. (2004) ESTHER, the database of the α/β-hydrolase fold superfamily of proteins. Nucleic Acids Research, 32, D145-D147. doi:10.1093/nar/gkh141
|
|
[35]
|
Corpet, F. (1988) Multiple sequence alignment with hierarchical clustering. Nucleic Acids Research, 16, 10881- 10890. doi:10.1093/nar/16.22.10881
|
|
[36]
|
Thompson, J.D., Higgins, D.G. and Gibson, T.J. (1994) CLUSTAL W: Improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Research, 22, 4673-4680.
doi:10.1093/nar/22.22.4673
|
|
[37]
|
Bernstein, F.C., Koetzle, T.F., Williams, G.J.B., Meyer, E.F., Brice, M.D. Jr., Rodgers, J.R., Kennard, O., Shimanouchi, T. and Tasumi, M. (1977) The protein databank: A computer-based archival file for macromolecular structures. Journal of Molecular Biology, 112, 535-542.
doi:10.1016/S0022-2836(77)80200-3
|
|
[38]
|
Berman, H.M., Westbrook, J., Feng, Z., Gilliland, G., Bhat, T.N., Weissig, H., Shindyalov, I.N. and Bourne, P.E. (2000) The Protein Data Bank. Nucleic Acids Research, 28, 235- 242. doi:10.1093/nar/28.1.235
|
|
[39]
|
Carletti, E., Li, H., Li, B., Ekstrom, F., Nicolet, Y., Loiodice, M., Gillon, E., Froment, M.T., Lockridge, O., Schopfer, L.M., Masson, P. and Nachon, F. (2008) Aging of choli- nesterases phosphorylated by tabun proceeds through odealkylation. Journal of the American Chemical Society, 130, 16011-16020. doi:10.1021/ja804941z
|
|
[40]
|
Felsenstein, J. (1989) PHYLIP: Phylogeny Inference Pack- age (Version 3.2). University of Washington, Seattle.
|
|
[41]
|
Treeview.
http://darwin.zoology.gla.ac.uk/~rpage/treeviewx/index.html
|
|
[42]
|
Perrière, G. and Gouy, M. (1996) WWW-query: An on-line retrieval system for biological sequence banks. Biochimie, 78, 364-369. doi:10.1016/000-9084(96)84768-7
|
|
[43]
|
De Lano, W. The PyMOL Molecular Graphics System, Schrödinger, LLC.
http://www.pymol.org
|
|
[44]
|
Liang, J., Edelsbrunner, H. and Woodward, C. (1998) Anat- omy of protein pockets and cavities: Measurement of binding site geometry and implications for ligand design. Protein Science, 7, 1884-1897.
doi:10.1002/pro.5560070905
|
|
[45]
|
Dundas, J., Ouyang, Z., Tseng, J., Binkowski, A., Turpaz, Y. and Liang, J. (2006) CASTp: Computed atlas of surface topography of proteins with structural and topographical mapping of functionally annotated residues. Nucleic Acids Research, 34, W116-W118.
doi:10.1093/nar/gkl282
|
|
[46]
|
Dehouck, Y., Grosfils, A., Folch, B., Gilis, D., Bogaerts, P. and Rooman, M. (2009) Fast and accurate predictions of protein stability changes upon mutations using statistical potentials and neural networks: PoPMuSiC-2.0. Bioin- formatics, 25, 2537-2543.
doi:10.1093/bioinformatics/btp445
|
|
[47]
|
Capriotti, E., Fariselli, P. and Casadi, R. (2005) I-Mutant2.0: Predicting stability changes upon mutation from the pro- tein sequence or structure. Nucleic Acids Research, 33, W306-W310. doi:10.1093/nar/gki375
|
|
[48]
|
Sali, A. and Blundell, T.L. (1993) Comparative protein modelling by satisfaction of spatial restraints. Journal of Molecular Biology, 234, 779-815.
doi:10.1006/jmbi.1993.1626
|
|
[49]
|
Marti-Renom, M.A., Stuart, A., Fiser, A., Sánchez, R., Melo, F. and Sali, A. (2000) Comparative protein structure modeling of genes and genomes. Annual Review of Biophysics and Biomolecular Structure, 29, 291-325.
|
|
[50]
|
Asanuma, K., Yagihashi, A., Yagihashi, A., Uehara, N., Kida, T. and Watanabe, N. (1999) Three point mutations of human butyrylcholinesterase in a Japanese family and the alterations of three-dimensional structure. Clinica Chimica Acta, 283, 33-42.
doi:10.1016/S0009-8981(99)00030-3
|
|
[51]
|
Pan, Y., Muzyka, J. and Zhan, C.G. (2009) Model of human butyrylcholinesterase (BChE) tetramer by homology modeling and dynamics simulation. Journal of Physical Chemistry B, 113, 6543-6552. doi:10.1021/jp8114995
|
|
[52]
|
Vyas, S., Beck, J.M., Xia, S., Zhang, J. and Hadad, C.M. (2010) Butyrylcholinesterase and G116H, G116S, G117H, G117N, E197Q and G117H/E197Q mutants: A molecular dynamics study. Chemico-Biological Interactions, 187, 241-245. doi:10.1016/j.cbi.2010.04.004
|
|
[53]
|
Zheng, F., Yang, W., Xue, L., Hou, S., Liu, J. and Zhan, C.G. (2010) Design of high-activity mutants of human butyrylcholinesterase against (-)-cocaine: Structural and energetic factors affecting the catalytic efficiency. Bio- chemistry, 49, 9113-9119. doi:10.1021/bi1011628
|
|
[54]
|
Bartels, C.F., Jensen, F.S., Lockridge, O., van der Spek A, F.L., Rubinstein, H.M., Lubrano, T., La Du, B.N. (1992) DNA mutation associated with the human butyrylcholinsterase K-variant and its linkage to the atypical variant mutation and other polymorphic sites. American Journal of Human Genetics, 50, 1086-1103.
|
|
[55]
|
Li, B., Duysen, E.G., Carlson, M. and Lockridge, O. (2008) The butyrylcholinesterase knockout mouse as a model for human butyrylcholinesterase deficiency. Journal of Phar- macology and Experimental Therapeutics, 324, 1146-1154.
doi:10.1124/jpet.107.133330
|
|
[56]
|
Li, B., Duysen, E.G. and Lockridge, O. (2008) The buty- rylcholinesterase knockout mouse is obese on a high-fat diet. Chemico-Biological Interactions, 175, 88-91.
doi:10.1016/j.cbi.2008.03.009
|
|
[57]
|
Duysen, E.G., Li, B. and Lockridge, O. (2009). The buty- rylcholinesterase knockout mouse as a research tool in the study of drug sensitivity, bio-distribution, obesity and Alzheimer’s disease. Expert Opinion on Drug Metabo- lism and Toxicology, 5, 523-528.
|
|
[58]
|
Indumathi, M., Rathnam, B., Sultan, D. and Lockridge, O. (2007) A medical health report on individuals with silent butyrylcholinesterase in the Vysya community of India. Clinica Chimica Acta, 378, 128-135.
doi:10.1016/j.cca.2006.11.005
|